+Compare
LABU
ETF ticker:
NYSE ARCA
AS OF
Loading...
Price
Loading...
Change
Loading...
Net Assets
1.12B

LABU Direxion Daily S&P Biotech Bull 3X ETF Forecast, Technical & Fundamental Analysis

Category Trading
GET INTRADAY SIGNALS
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I.Advisor
a Summary for LABU with price predictions
08:00 PM EDT Jun 04, 2023

LABU sees its Stochastic Oscillator ascends from oversold territory

On June 02, 2023, the Stochastic Oscillator for LABU moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 71 instances where the indicator left the oversold zone. In of the 71 cases the stock moved higher in the following days. This puts the odds of a move higher at over .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on June 02, 2023. You may want to consider a long position or call options on LABU as a result. In of 102 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

LABU moved above its 50-day moving average on May 03, 2023 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where LABU advanced for three days, in of 302 cases, the price rose further within the following month. The odds of a continued upward trend are .

LABU may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 214 cases where LABU Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for LABU moved out of overbought territory on May 11, 2023. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 25 similar instances where the indicator moved out of overbought territory. In of the 25 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Moving Average Convergence Divergence Histogram (MACD) for LABU turned negative on May 24, 2023. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 40 similar instances when the indicator turned negative. In of the 40 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LABU declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

Fear & Greed
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are ABBVIE (NYSE:ABBV), Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Regeneron Pharmaceuticals (NASDAQ:REGN), Moderna (NASDAQ:MRNA), Biogen (NASDAQ:BIIB), Horizon Therapeutics Public Limited (NASDAQ:HZNP), Exact Sciences Corp (NASDAQ:EXAS), Incyte Corp (NASDAQ:INCY), Sarepta Therapeutics (NASDAQ:SRPT).

Industry description

The investment seeks daily investment results, before fees and expenses, of 300% of the daily performance of the S&P Biotechnology Select Industry Index ("index"). The fund invests at least 80% of its net assets (plus borrowing for investment purposes) in financial instruments and securities of the index, exchange-traded funds ("ETFs") that track the index and other financial instruments that provide daily leveraged exposure to the index or ETFs that track the index. The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards ("GICS"). The fund is non-diversified.

Market Cap

The average market capitalization across the Direxion Daily S&P Biotech Bull 3X ETF ETF is 6.42B. The market cap for tickers in the group ranges from 150.88M to 241.48B. ABBV holds the highest valuation in this group at 241.48B. The lowest valued company is ATRA at 150.88M.

High and low price notable news

The average weekly price growth across all stocks in the Direxion Daily S&P Biotech Bull 3X ETF ETF was 8%. For the same ETF, the average monthly price growth was 2%, and the average quarterly price growth was 0%. BHVN experienced the highest price growth at 39%, while ZNTL experienced the biggest fall at -18%.

Volume

The average weekly volume growth across all stocks in the Direxion Daily S&P Biotech Bull 3X ETF ETF was -44%. For the same stocks of the ETF, the average monthly volume growth was -54% and the average quarterly volume growth was -51%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 59
P/E Growth Rating: 81
Price Growth Rating: 50
SMR Rating: 89
Profit Risk Rating: 86
Seasonality Score: 25 (-100 ... +100)
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I. Advisor
published General Information

General Information

Category Trading

Profile
Fundamentals
Details
Category
Trading--Leveraged Equity
Address
Direxion Shares ETF Trust33 Whitehall Street,10th FloorNew York
Phone
866-476-7523
Web
http://www.direxioninvestments.com/
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CBMIX37.98N/A
N/A
Allspring C&B Mid Cap Value Admin
RWIGX56.09N/A
N/A
American Funds Capital World Gr&Inc R6
TEMGX8.67N/A
N/A
Templeton Global Smaller Comp A
HEIIX13.69N/A
N/A
Hennessy Equity and Income Institutional
MSFAX32.59N/A
N/A
Morgan Stanley Inst Global Franchise I

LABU and

Correlation & Price change

A.I.dvisor indicates that over the last year, LABU has been loosely correlated with SSO. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if LABU jumps, then SSO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LABU
1D Price
Change %
LABU100%
+1.19%
SSO - LABU
65%
Loosely correlated
-0.46%
SPXL - LABU
65%
Loosely correlated
-0.64%
QLD - LABU
64%
Loosely correlated
+0.10%
TQQQ - LABU
64%
Loosely correlated
+0.22%
SOXL - LABU
54%
Loosely correlated
-4.77%